Amrutam Pharmaceuticals Private Limited
About Amrutam Pharmaceuticals Private Limited
Data last updated:
Amrutam Pharmaceuticals Private Limited is a private limited company based in Gwalior, Madhya Pradesh, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 21 March 2023.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U21003MP2023PTC064911.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Agnim Gupta and Chandra Kanta Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gwalior, Madhya Pradesh.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.98 Cr, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹4.86 Lakh (net margin 2.5%) and EBITDA of ₹7.79 Lakh (EBITDA margin 3.9%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years.
As per MCA filings, the company has open charges of ₹51.15 Lakh on record.
Company details
Contact details
Amrutam Pharmaceuticals Private Limited's registered office is in Gwalior, Madhya Pradesh.
- Registered AddressChitragupt Ganj, Near Kailash Talkies, Gwalior, Madhya Pradesh, India – 474001
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Amrutam Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Amrutam Pharmaceuticals Private Limited, buy the company report.
Financials of Amrutam Pharmaceuticals Private Limited
FY 2025 filings availableAmrutam Pharmaceuticals Private Limited reported revenue of ₹1.98 Cr (down 11% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 9% over three years, including a 11% fall in the latest year. EBITDA fell 76% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹7.79 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹4.86 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 3.9% | |
| Net Profit Margin | 2.5% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Amrutam Pharmaceuticals Private Limited, buy the company report.
Board of directors of Amrutam Pharmaceuticals Private Limited
Amrutam Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Agnim Gupta | Director | 21 Mar 2023 | 3 Years 7 Months | Current |
| Chandra Kanta Gupta Also directs: Mercury M. Agency Private Limited | Director | 21 Mar 2023 | 3 Years 7 Months | Current |
| Stuti Gupta Also directs: Onashi Nature Private Limited | Director | 12 Apr 2023 | 3 Years 6 Months | Current |
Peer comparison
Amrutam Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pentavox Herbals Private Limited | ₹2 Cr (FY 2025) | 2.0% | Ludhiana, Punjab, India | |||
| Kaithey Health Care Private Limited | ₹2 Cr (FY 2023) | 16.0% | Muzaffarnagar, Uttar Pradesh, India | |||
| Amrutam Pharmaceuticals Private Limitedthis company | ₹1.98 Cr (FY 2024) | ₹4.86 Lakh | 2.5% | -11.0% | Gwalior, Madhya Pradesh, India | |
| BLBK Pharmaceuticals Private Limited | ₹1.98 Cr (FY 2025) | -27.0% | Delhi, India | |||
| Retort Pharmaceuticals Private Limited | ₹1.97 Cr (FY 2024) | -7.0% | Chennai, Tamil Nadu, India | |||
| Tooba Pharmaceuticals Private Limited | ₹1.97 Cr (FY 2024) | 57.0% | Aurangabad, Maharashtra, India |
To see the full peer comparison of Amrutam Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Feb 2025 | 101098483 | Hdfc Bank Limited | ₹20.07 Lakh | Open | |
| 31 Dec 2023 | 100865893 | Hdfc Bank Limited | ₹10.98 Lakh | Open | |
| 06 Dec 2023 | 100864452 | Hdfc Bank Limited | ₹20.1 Lakh | Open |
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Amrutam Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Amrutam Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Amrutam Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Amrutam Pharmaceuticals Private Limited has 3 board changes on record since 2023: 3 appointments. The latest: Stuti Gupta was appointed as Director on 12 Apr 2023.
Frequently asked questions
Amrutam Pharmaceuticals is an active private limited company based in Gwalior, Madhya Pradesh, India. The company works in paper and paper products, within the paper industry. It was incorporated on 21 March 2023 (3+ years old) and is registered under CIN U21003MP2023PTC064911.
Amrutam Pharmaceuticals has 3 current directors:
- Agnim Gupta - Director
- Chandra Kanta Gupta - Director
- Stuti Gupta - Director
The latest financial statements of Amrutam Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Amrutam Pharmaceuticals is U21003MP2023PTC064911. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Amrutam Pharmaceuticals was incorporated on 21 March 2023, making it 3+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Amrutam Pharmaceuticals by revenue are Pentavox Herbals Private Limited, Kaithey Health Care Private Limited, BLBK Pharmaceuticals Private Limited, Retort Pharmaceuticals Private Limited, Tooba Pharmaceuticals Private Limited, all in the Healthcare industry (Ayurvedic Products and Services, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Stuti Gupta was appointed as Director on 12 Apr 2023. Agnim Gupta was appointed as Director on 21 Mar 2023. Chandra Kanta Gupta was appointed as Director on 21 Mar 2023.
The registered office of Amrutam Pharmaceuticals is at Chitragupt Ganj, Near Kailash Talkies, Gwalior, Madhya Pradesh, India – 474001.
Amrutam Pharmaceuticals operates in the paper industry, in the paper and paper products segment.
Amrutam Pharmaceuticals has open charges of ₹51.15 Lakh and no satisfied charges on record as per latest MCA filings.
Amrutam Pharmaceuticals can be reached at its registered office: Chitragupt Ganj, Near Kailash Talkies, Gwalior, Madhya Pradesh, India – 474001.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
